Ilia I. Ouspenski

Array ( [id] => 8476712 [patent_doc_number] => 20120276120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'T-Cell Stimulating Protein B and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/505263 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24685 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359819 [patent_doc_number] => 20120214972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCYTE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/908517 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 36504 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12908517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164903 [patent_doc_number] => 20110195073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/905796 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19917 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195073.pdf [firstpage_image] =>[orig_patent_app_number] => 12905796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140071 [patent_doc_number] => 08580528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Method for prognosticating the clinical response of a patient to B-lymphocyte inhibiting or depleting therapy' [patent_app_type] => utility [patent_app_number] => 12/905625 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13982 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12905625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346847 [patent_doc_number] => 20120207770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'ANTIPROLIFERATIVE AGENT' [patent_app_type] => utility [patent_app_number] => 13/501768 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20969 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8696924 [patent_doc_number] => 20130058933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'MONOVALENT LIGANDS OF THE HUMAN CD28 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/501015 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1776 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054585 [patent_doc_number] => 20110110945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Immunoglobulin Fusion Proteins and Methods of Making' [patent_app_type] => utility [patent_app_number] => 12/899073 [patent_app_country] => US [patent_app_date] => 2010-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 30323 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110945.pdf [firstpage_image] =>[orig_patent_app_number] => 12899073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358635 [patent_doc_number] => 20120213793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/501730 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11454 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429680 [patent_doc_number] => 20120251556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Combination Immunotherapy for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 13/498570 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11092 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114337 [patent_doc_number] => 08158386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist' [patent_app_type] => utility [patent_app_number] => 12/888713 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6107 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158386.pdf [firstpage_image] =>[orig_patent_app_number] => 12888713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943530 [patent_doc_number] => 20110104150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'ANTI-CD19 ANTIBODIES AND USES IN B CELL DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/885341 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 90355 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104150.pdf [firstpage_image] =>[orig_patent_app_number] => 12885341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125424 [patent_doc_number] => 20110086037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'METHOD OF TREATING INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/883407 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26175 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086037.pdf [firstpage_image] =>[orig_patent_app_number] => 12883407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9957417 [patent_doc_number] => 09005616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Methods and compositions for the inhibition of transplant rejection' [patent_app_type] => utility [patent_app_number] => 13/392399 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 35511 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964245 [patent_doc_number] => 09011853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'B7-H4 fusion proteins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/392811 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 72 [patent_no_of_words] => 61065 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978445 [patent_doc_number] => 20110071278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'ANTIBODIES THAT RECOGNIZE CUTTING EDGE WITHIN THE TGF- BETA ACTIVATION CONTROLLING REGION' [patent_app_type] => utility [patent_app_number] => 12/856195 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11080 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071278.pdf [firstpage_image] =>[orig_patent_app_number] => 12856195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749419 [patent_doc_number] => 08840889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Methods of modulating immune function' [patent_app_type] => utility [patent_app_number] => 13/390054 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 48 [patent_no_of_words] => 150436 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099816 [patent_doc_number] => 08563694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Fully human antibodies to BTLA' [patent_app_type] => utility [patent_app_number] => 13/388028 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 37580 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009159 [patent_doc_number] => 08524455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Methods and compositions related to TR4 ligand' [patent_app_type] => utility [patent_app_number] => 12/842569 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 34091 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12842569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754603 [patent_doc_number] => 20120027759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHODS OF ENHANCING T CELL RESPONSIVENESS' [patent_app_type] => utility [patent_app_number] => 12/835410 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15143 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027759.pdf [firstpage_image] =>[orig_patent_app_number] => 12835410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509176 [patent_doc_number] => 20120308585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR USE IN CELLULAR THERAPIES' [patent_app_type] => utility [patent_app_number] => 13/382426 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11501 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382426 [rel_patent_id] =>[rel_patent_doc_number] =>)